Clune & Associates, Ltd. Abbott Laboratories Transaction History
Clune & Associates, Ltd.
- $365 Billion
- Q2 2025
A detailed history of Clune & Associates, Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Clune & Associates, Ltd. holds 14,794 shares of ABT stock, worth $1.99 Million. This represents 0.55% of its overall portfolio holdings.
Number of Shares
14,794
Previous 14,917
0.82%
Holding current value
$1.99 Million
Previous $1.98 Billion
1.69%
% of portfolio
0.55%
Previous 0.61%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,582Shares Held
1.38BCall Options Held
9.71MPut Options Held
8.86M-
Vanguard Group Inc Valley Forge, PA170MShares$22.8 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.4 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.97 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.81 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $235B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...